Discover investment opportunities in Best Stocks To Buy Under $60 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Stocks To Buy Under $60 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Stocks To Buy Under $60 using our Smart AI Filter.
10 stocks found for "Best Stocks To Buy Under $60"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.79 Risk measure | ±28.3% Price volatility | 9.6 Valuation | 3.25% Annual yield | |||
1.06 Risk measure | ±36.8% Price volatility | 7.2 Valuation | 0.59% Annual yield | |||
1.06 Risk measure | ±59.4% Price volatility | 23.2 Valuation | 0.00% Annual yield | |||
0.72 Risk measure | ±40.2% Price volatility | 17.0 Valuation | 3.18% Annual yield | |||
0.61 Risk measure | ±38.9% Price volatility | 6.7 Valuation | 5.08% Annual yield | |||
1.73 Risk measure | ±64.4% Price volatility | 28.8 Valuation | 0.00% Annual yield | |||
0.35 Risk measure | ±28.9% Price volatility | 6.7 Valuation | 5.29% Annual yield | |||
0.32 Risk measure | ±24.8% Price volatility | 8.7 Valuation | 6.75% Annual yield | |||
1.75 Risk measure | ±49.8% Price volatility | 26.5 Valuation | 0.19% Annual yield | |||
0.23 Risk measure | ±21.9% Price volatility | 9.2 Valuation | 6.32% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What factors make DBRG (DigitalBridge Group, Inc.) appealing for growth investors?
A: DBRG focuses on digital infrastructure investments, which are crucial in a data-driven economy. The growing demand for data centers and broadband provides a potential growth catalyst. Investors should consider DBRG’s strategic acquisitions and market position.
Q: Is uranium mining company UEC (Uranium Energy Corp.) a suitable choice for ESG-focused investors?
A: UEC, focused on uranium mining, presents challenges for ESG investors due to environmental concerns related to mining operations. Potential regulatory shifts towards cleaner energy may influence its market.
Q: How does VZ (Verizon Communications Inc.) fit into a dividend income strategy?
A: VZ is known for stable dividend payments, making it attractive for income-focused investors. Its telecommunications services provide consistent cash flow, though competition and industry changes may impact future payouts.
Q: How has DAL (Delta Air Lines, Inc.) typically performed in economic downturns?
A: DAL historically faces volatility during economic downturns as consumer travel decreases. However, its strategic partnerships and domestic market strength may offer recovery opportunities when economic conditions improve.
Q: What competitive advantages does BMY (Bristol-Myers Squibb Company) have in pharmaceuticals?
A: BMY benefits from a strong pipeline and portfolio in oncology and cardiovascular treatments. Established R&D capabilities and recent patent extensions bolster its competitive position in the industry.
Q: Are there any geopolitical risks impacting SLB (Schlumberger Limited)?
A: SLB, a key player in oilfield services, faces geopolitical risks including regulatory changes and regional instability, which can affect oil prices and demand for its services.
Trial data released by Novo Nordisk showed a significant reduction in the risk of heart attack, stroke or death in certain patients on its blockbuster weight-loss treatment Wegovy, compared with drugs produced by the Danish firm's U.S. rival Eli Lilly. The companies are the leading players in the weight loss space, both grappling with challenges from copycat compounders and the race to develop next-generation treatments.
Read moreIn late August, the U.S. government agreed to take roughly a 10 percent equity stake in Intel, converting about $8.9 billion of previously committed CHIPS and Secure Enclave funds into shares. This is an unprecedented move that effectively swaps subsidies for ownership.
Read more